SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BLISS GVS PHARMA

BSE: 506197 22 Aug 2025
Healthcare
₹ 161.45
Bliss GVS Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

BLISS GVS PHARMA - Share Price & Details

Market Cap
₹1,723
High /Low
191.0 / 105.0
Stock P/E
16.2
Book Value
₹99.7
Dividend Yield
0.31
ROCE
11.7
ROE
₹8.36
Face Value
1.0
PEG Ratio
0.37
EVEBITDA
₹7.93
Debt
88.1
CMP / FCF
105.0
Debt to equity
₹0.08
NP Ann
90.3
High price all time
230.0
Piotroski score
₹4.0
Graham Number
151.0
No. Eq. Shares
10.6
Net CF
₹0.23
Net profit
112
Price to book value
1.6
Interest Coverage
₹14.2
Low price all time
0.95
Industry PE
32.8
Reserves
₹1,040
Free Cash Flow
₹33.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
BLISS GVS PHARMA LTD.1739.57210.531633.641.981,72316.2
HESTER BIOSCIENCES LTD.644.3678.38634.99.21171245.5
SYNCOM FORMULATIONS (INDIA) LT1225.67157.291165.470.21163128.3

Peer Comparison Chart


About BLISS GVS PHARMA

Bliss GVS Pharma Limited, with Security Code 506197, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Where Could Bliss GVS Pharma Limited (BLISSGVS) Be Headed - Achieve breakthrough performance in the market

(04 Aug 2025)
Where Could Bliss GVS Pharma Limited (BLISSGVS) Be Headed ✌️【Stock Buzz】✌️ Free access to high-return stock ideas with potential to double,...
Read more →

Macro Trends and Their Impact on Bliss GVS Pharma Limited (506197) - Unlock daily market insights for better trades

(04 Aug 2025)
Macro Trends and Their Impact on Bliss GVS Pharma Limited (506197) ✌️【Stock Observations】✌️ Free break-even services and professional advice...
Read more →

Bliss GVS Pharma Limited (506197) Expands into New Market - Invest confidently with professional guidance

(03 Aug 2025)
Bliss GVS Pharma Limited (506197) Expands into New Market ✌️【Investor Updates】✌️ Grow your wealth with actionable stock advice and live...
Read more →

Bliss GVS Pharma posts Q1 FY26 PAT higher at Rs. 43.03 Cr

(01 Aug 2025)
Bliss GVS Pharma has reported total income of Rs. 242.92 crores during the period ended June 30, 2025.
Read more →

Bliss GVS Pharma Achieves 52-Week High Amid Broader Market Decline

(31 Jul 2025)
Bliss GVS Pharma's stock reached a new 52-week high of Rs. 190.65, reflecting strong performance amid a broader market decline.
Read more →

Pharma stock skyrockets 17% after company’s net profit increases by 167% QoQ

(30 Jul 2025)
Synopsis: Bliss GVS Pharma Ltd Q1 revenue rose 13% to Rs. 207 Crores YoY, and net profit grew 167% to Rs. 44.4 Crores QoQ. telegram channel...
Read more →

Company Updates